// App-Quantinova.ai

2542 : Thrombopoietin-Receptor Agonist in Systemic Lupus Erythematosus Associated Immune Thrombocytopenia: Results of the 16 Patients from the French Cohort

Researchers

Presenter

  • Louis Terriou

Principal Investigators

  • Zelie Guitton

  • Miguel Hie

  • Nadine magy-Bertrand

  • Sylvain Audia

  • Matthieu Mahevas

  • Bertrand Godeau

  • Zahir Amoura

  • James B. Bussel

  • Mohamed Hamidou

  • Eric Rosenthal

  • jean-Christophe Lega

  • Raphaele nove-Josserand

  • Bertrand Lioger

  • Axel Chaminade

Medical Centers

  • internal medecine, CHRU Besancon, Besancon, France

  • Department of Internal Medecine, clinical immunology, Hopital HURIEZ CHRU Lille, Lille, France

  • internal medecine, CHRU Reunion, Saint-Pierre, France

  • Department of Internal Medicine, Cochin Hospital, Paris, France

  • Internal Medicine, French referral center for adults immune cytopenia, Henri Mondor Hospital, AP-HP, UPEC University, Creteil, France

  • Department of Internal Medicine, Cochin Hospital, Paris, France

  • Internal medicine, CHU Lyon, Lyon, France

  • Division of Pediatric Hematology/Oncology, Department of Pediatrics, Weill Cornell Medicine, New York, NY

  • internal medecine, CHRU Nice, Nice, France

  • Department of Radiotherapy, Pitie-Salpetriere University Hospital, Paris, France

  • APHP, Pitie-Salpetriere Hospital, paris, France

Locations

  • France

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

  • Antiphospholipid syndrome

  • Immune thrombocytopenia

  • Thrombocytopenia

Biomarkers

  • Circulating tumor cells

  • Cytochrome C

Drug/Treatment

  • Mycophenolate mofetil

  • CKD-4101

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Mycophenolic acid

  • Oraprine

  • Ciclosporine

  • Tocilizumab

  • Eltrombopag

  • Romiplostim

  • Abatacept

  • Rituximab

  • IVIG

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved